3α-hydroxy-6-ethyl-7-keto-5β-cholan-24-oic acid NEW

$0.00 1kg

$0.00 5kg

$0.00 10kg

Min. Order1kg
Purity99%
Cas No915038-26-5
Supply Ability500KG
Update time2026-01-04

Hangzhou ICH Biofarm Co., Ltd

VIP3Y

China

Since:2006-07-19

Address:Room 1305, Building A, No. 274 Tianmushan Road and No. 2-18 (Double) Wantang Road, Xihu District, Ha

show less show more

Chemical Properties

Product Name	3α-hydroxy-6-ethyl-7-keto-5β-cholan-24-oic acid
CAS No	915038-26-5
EC-No
Min. Order	1kg
Purity	99%
Supply Ability	500KG
Release date	2026/01/04

- 3α-hydroxy-6-ethyl-7-keto-5β-cholan-24-oic acid is a chemical compound with the molecular formula C26H42O4 and the molecular weight 418.62 g/mol .

- It is a white solid that is soluble in dichloromethane, chloroform, ethyl acetate, DMSO and methanol .

- It has a boiling point of 561.5±25.0 °C and a pKa of 4.76±0.10 .

- It is an intermediate used in the synthesis of 6α-ethyl ursodeoxycholic acid, which is an epimer of obeticholic acid .

- Obeticholic acid is a derivative of the bile acid chenodeoxycholic acid and a potent activator of the farnesoid X nuclear receptor, which reduces liver fat and fibrosis in animal models of fatty liver disease .

- Obeticholic acid is also used to treat primary biliary cholangitis, a chronic liver disease caused by autoimmune destruction of the bile ducts .

Email: pharmchem1@ichemie.com

Tel&Whatsapp:+86-18771921569

show less show more

Company Profile Introduction

Our company specializes in the research, development and production of APIs and pharmaceutical intermediates. At the same time, our core R&D team has more than 20 years of drug R&D experience. Under the support of a good research and development environment and a professional technical team, our company has obtained rich experience and outstanding achievements of new drugs and generic drugs projects. On the one hand, we are focused on the research and development and the optimization of production processes of generic drugs such as anti-viral and anti-malaria. On the other hand, we are also committed to the cooperative development of innovative drugs in the fields of respiratory system and hypoglycemia. We can provide technical support in all key links of drug research and development for drug production and distribution companies.